Atlas Trials

Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer

Clinical trial NCT00072176 · COMPLETED

Trial details

NCT number
NCT00072176
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Endometrial AdenocarcinomaEndometrial Adenosquamous Cell CarcinomaEndometrial Clear Cell CarcinomaEndometrial Papillary Serous CarcinomaRecurrent Endometrial CarcinomaStage IIIA Endometrial CarcinomaStage IIIB Endometrial CarcinomaStage IIIC Endometrial CarcinomaStage IVA Endometrial CarcinomaStage IVB Endometrial Carcinoma
Start date
2004-05-01
Primary completion
2009-05-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.